Status: Closed — this petition is no longer accepting signatures.
Final supporters
Dear Anabela,
TrialScope’s disclosure solution simplifies the complexities of clinical trial transparency for trial sponsors. Our customers, who comprise more than 20 of the largest global biopharmaceutical companies, represent approximately 40% of all CTAs publicly available on EU CTR and more than 58% of the results records.
To support these leading trial sponsors, TrialScope continues to evolve our disclosure solution, including support for EudraCT and the new EU portal. To develop a robust and high-quality system — one that will allow sponsors to submit accurate, timely data to the new EU portal — requires TrialScope to have early and direct access to the portal test environment. To date, this direct access has been granted only to selected trial sponsors participating in testing of the portal.
On behalf of our customers, we request access to the portal to begin development. In the spirit of partnership, we envision the EMA benefiting as well; we can significantly reduce the workload on the EU support team by acting as the initial point of contact for almost half of all the submissions to the future portal.
Our request is supported by the following TrialScope customers:
<Final List Provided to EMA upon customer signatures>
More like this
LDN Petition to the European Parliament
Patients and Health Advocates in Support of Proposed Changes to the PMPRB and a…
2 Comments
get this sorted. transparency is for everyone and blocking the people who actually do the work makes zero sense.
Share Petition
Don't stop at signing, share the petition link with friends to multiply our impact
Copy link or share directly
Status: Closed — this petition is no longer accepting signatures.
Final supporters
Dear Anabela,
TrialScope’s disclosure solution simplifies the complexities of clinical trial transparency for trial sponsors. Our customers, who comprise more than 20 of the largest global biopharmaceutical companies, represent approximately 40% of all CTAs publicly available on EU CTR and more than 58% of the results records.
To support these leading trial sponsors, TrialScope continues to evolve our disclosure solution, including support for EudraCT and the new EU portal. To develop a robust and high-quality system — one that will allow sponsors to submit accurate, timely data to the new EU portal — requires TrialScope to have early and direct access to the portal test environment. To date, this direct access has been granted only to selected trial sponsors participating in testing of the portal.
On behalf of our customers, we request access to the portal to begin development. In the spirit of partnership, we envision the EMA benefiting as well; we can significantly reduce the workload on the EU support team by acting as the initial point of contact for almost half of all the submissions to the future portal.
Our request is supported by the following TrialScope customers:
<Final List Provided to EMA upon customer signatures>
2 Comments
The EMA needs to stop dragging their feet. If these guys handle half the paperwork they should have been given access months ago. Fix this bureaucracy already.
get this sorted. transparency is for everyone and blocking the people who actually do the work makes zero sense.
Share Petition
Don't stop at signing, share the petition link with friends to multiply our impact
Petitions like this
Other petitions you might want to support
Scan to share
Anyone who scans this can sign the petition.
The EMA needs to stop dragging their feet. If these guys handle half the paperwork they should have been given access months ago. Fix this bureaucracy already.